Sirona Biochem Announces Close of Private Placement
VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) — Vancouver, British Columbia – April 4, 2024 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (“Sirona”) has closed its private placement (Private Placement”) for gross proceeds of $132,500 CAD. The Private Placement consists of 1,325,000 units, (the “Units”) at a price of $0.10 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two. All securities issued under the Private Placement are subject to statutory hold periods expiring on August 4, 2024.
Related news for (SRBCF)
- Sirona Biochem Announces Debenture Financing
- Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
- Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report
- GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
- SIRONA BIOCHEM Corporate Update April 2024